Ministry of National Health Services, Regulations and Coordination

Drug Regulatory Authority of Pakistan

National Control Laboratory for Biologicals

Home Up DBER About Us Contents FAQs WHO LINKS

Hepatitis B

NCLB implements Lot release and Lab testing of Biological Drugs as per Schedule I of DRAP Act, 2012 (Act No. XXI of 2012)

and is part of DRAP Authority under Section 3 of this Act.

2021 is 21st year of service of NCLB


inside nclb left wing nclb enterance inside nclb right wing


Manufactured by AVP Islamabad WHO TRS
AVP imports the concentrate and fill it locally in single dose ampoules under GMP compliant conditions and test it according to WHO requirements. Amendment 1997,
WHO TRS No 889, Annex 4

  Hepatitis B vaccines, DNA recombinant
Title: Requirements for Hepatitis B vaccines made by Recombinant DNA Techniques;
Adopted 1988,
WHO TRS No 786, Annex 2

  Supplementary for guidance:
Title: Biological products prepared by recombinant DNA technology; Adopted 1990,
WHO TRS No 814, Annex 3
List of Products presently under going Lot Release Performance of NCLB Lot Release system from 2007 onwards  

Home ] Up ]

Send mail to with questions or comments about this web site.
Copyright 2011 National Control Laboratory for Biologicals
Last modified: 13-Jul-2021